Keymed Biosciences Announces 2022 Annual Results: Efficiently Promotes Clinical Progress Proactively Develops Global Strategic Collaboration
- Written by PR Newswire
CHENGDU, China, March 18, 2023 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) announced its 2022 annual results. Focused on unmet clinical needs, the Company continued to efficiently develop innovative and differentiated pipelines, proactively carry out global strategic collaboration and accelerate its commercialization progress in 2022.
Deve...














